Form 8-K - Current report:
SEC Accession No. 0001798749-24-000003
Filing Date
2024-01-08
Accepted
2024-01-08 07:59:17
Documents
46
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20240108x8k.htm   iXBRL 8-K 45431
2 EX-99.1 tmb-20240108xex99d1.htm EX-99.1 49869
3 GRAPHIC tmb-20240108xex99d1g001.jpg GRAPHIC 73625
4 GRAPHIC tmb-20240108xex99d1g002.jpg GRAPHIC 246881
5 GRAPHIC tmb-20240108xex99d1g003.jpg GRAPHIC 131998
6 GRAPHIC tmb-20240108xex99d1g004.jpg GRAPHIC 101562
7 GRAPHIC tmb-20240108xex99d1g005.jpg GRAPHIC 96497
8 GRAPHIC tmb-20240108xex99d1g006.jpg GRAPHIC 61973
9 GRAPHIC tmb-20240108xex99d1g007.jpg GRAPHIC 75334
10 GRAPHIC tmb-20240108xex99d1g008.jpg GRAPHIC 54263
11 GRAPHIC tmb-20240108xex99d1g009.jpg GRAPHIC 88244
12 GRAPHIC tmb-20240108xex99d1g010.jpg GRAPHIC 98391
13 GRAPHIC tmb-20240108xex99d1g011.jpg GRAPHIC 110213
14 GRAPHIC tmb-20240108xex99d1g012.jpg GRAPHIC 42640
15 GRAPHIC tmb-20240108xex99d1g013.jpg GRAPHIC 69987
16 GRAPHIC tmb-20240108xex99d1g014.jpg GRAPHIC 129640
17 GRAPHIC tmb-20240108xex99d1g015.jpg GRAPHIC 68295
18 GRAPHIC tmb-20240108xex99d1g016.jpg GRAPHIC 71728
19 GRAPHIC tmb-20240108xex99d1g017.jpg GRAPHIC 86783
20 GRAPHIC tmb-20240108xex99d1g018.jpg GRAPHIC 96935
21 GRAPHIC tmb-20240108xex99d1g019.jpg GRAPHIC 83654
22 GRAPHIC tmb-20240108xex99d1g020.jpg GRAPHIC 66401
23 GRAPHIC tmb-20240108xex99d1g021.jpg GRAPHIC 88546
24 GRAPHIC tmb-20240108xex99d1g022.jpg GRAPHIC 98105
25 GRAPHIC tmb-20240108xex99d1g023.jpg GRAPHIC 116891
26 GRAPHIC tmb-20240108xex99d1g024.jpg GRAPHIC 104719
27 GRAPHIC tmb-20240108xex99d1g025.jpg GRAPHIC 89365
28 GRAPHIC tmb-20240108xex99d1g026.jpg GRAPHIC 85691
29 GRAPHIC tmb-20240108xex99d1g027.jpg GRAPHIC 66151
30 GRAPHIC tmb-20240108xex99d1g028.jpg GRAPHIC 71663
31 GRAPHIC tmb-20240108xex99d1g029.jpg GRAPHIC 74125
32 GRAPHIC tmb-20240108xex99d1g030.jpg GRAPHIC 69950
33 GRAPHIC tmb-20240108xex99d1g031.jpg GRAPHIC 71704
34 GRAPHIC tmb-20240108xex99d1g032.jpg GRAPHIC 101540
35 GRAPHIC tmb-20240108xex99d1g033.jpg GRAPHIC 37940
  Complete submission text file 0001798749-24-000003.txt   4277204

Data Files

Seq Description Document Type Size
36 EX-101.SCH tmb-20240108.xsd EX-101.SCH 3124
37 EX-101.LAB tmb-20240108_lab.xml EX-101.LAB 16578
38 EX-101.PRE tmb-20240108_pre.xml EX-101.PRE 10780
40 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240108x8k_htm.xml XML 4990
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 24518375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)